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ABSTRACT: Quantitative polymerase chain reaction is the
current “golden standard” for quantification of nucleic acids;
however, its utility is constrained by an inability to easily and
reliably detect multiple targets in a single reaction. We have
successfully overcome this problem with a novel combination
of two widely used approaches: target-specific multiplex
amplification with 15 cycles of polymerase chain reaction
(PCR), followed by single-molecule detection of amplicons
with atomic force microscopy (AFM). In test experiments
comparing the relative expression of ten transcripts in two
different human total RNA samples, we find good agreement
between our single reaction, multiplexed PCR/AFM data, and
data from 20 individual singleplex quantitative PCR reactions.
This technique can be applied to virtually any analytical problem requiring sensitive measurement concentrations of multiple
nucleic acid targets.
High-throughput transcriptomic assays, such as microarraysor RNA-Seq, allow identification of gene expression
signatures consisting of hundreds-to-thousands of genes.
However, these high-throughput techniques are costly and
time-consuming (turnaround time one-to-several days), need
centralized processing in many cases, and are not very sensitive
in terms of the amount of input material.1,2 For example, the
hybridization-based, nCounter System requires ∼100 ng of
input total RNA for gene expression studies, with a typical assay
time of 16 h.3 In particular, assay sensitivity is becoming an
important figure of merit as interest grows in studying minute
quantity samples, such as needle biopsies, aspirates, and
circulating tumor cells (CTCs),4 rather than bulk tissue.5−7
At the same time, there is no need to use cost- and time-
intensive high-throughput techniques in many situations where
an assay of several-to-tens of genes will suffice, such as in the
case of established biomarker panels.8−11
Real time-polymerase chain reaction (qPCR) is the golden
standard for gene expression-based biomarker assays, due to its
sensitivity (single-molecule in the ideal case) and broad
dynamic range. However, traditional qPCR is difficult to
multiplex, and as a result, multitarget experiments require many
single reactions to be conducted in parallel, either in microplate
format or in the case of limited-quantity samples, using
preamplification and proprietary microfluidic platforms; both
approaches which add substantial cost, time, and complexity to
the analysis.12,13 Multiplexing standard PCR is problematic
because target sequences are typically amplified nonuniformly,
which results in misrepresentation of low-abundance and/or
“difficult” amplicons due to the depletion of reagents (dNTP
and primers) and inhibition of polymerase by amplicons;14
another problem is off-target primer binding and primer dimer
formation, for which the probability grows as the number of
primer pairs in multiplex increases; note that both these effects
accumulate over a reaction time course and result in artifacts at
a high number of cycles.
To achieve simple and effective multiplexing of targets in one
qPCR reaction, we have combined low-cycle-number (<15
cycles), target-specific multiplex amplification with single-
molecule amplicon detection using atomic force microscopy
(AFM). By limiting the number of PCR cycles, we seek to
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avoid the differential amplification distortion present in normal
qPCR, which in most cases requires 30+ amplification cycles.
We distinguish amplicons by their sizes, and given the high
sizing precision achievable with AFM, typically <3% CV,15,16 up
Figure 1. (a) Bioanalyzer chromatogram of human reference total RNA 10-plex amplicons (1 μL, conc. 800 pg/μL) compared to (b) size
distribution of amplicons measured with AFM (est. ∼1 μL, conc. 10 pg/μL; 2500 molecules). Note that the AFM-determined amplicon sizes are
plotted on a logarithmic scale for comparison purposes. Human brain total RNA 10-plex measured by (c) a bioanalyzer (800 pg/μL) and (d) AFM
(10 pg/μL; 1500 molecules).
Figure 2. (a) 10 × 10 μm AFM image of 10plex RT-PCR products (15 amplification cycles) produced using Universal Total Human Reference RNA
as a template. (b) First inset shows various PCR amplicons highlighted in white with their associated backbone contour measurements. (c) Second
inset shows individual amplicons classified by species. Note that background objects are not identified as amplicons due to their nonlinear shape (∗
and ∗∗) or because they were shorter than the smallest expected amplicon (∗∗∗).
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to tens of targets can be discriminated simultaneously. Because
individual amplicons are easily detected by AFM, our approach
has orders of magnitude higher sensitivity (1000×) compared
to bulk fluorescent techniques such as microarray and capillary
electrophoresis; further, no fluorescent dyes or any other types
of labeling are used, thus reducing the complexity and cost of
the analysis.
We demonstrate the technique by measuring the relative
expression level of ten human genes in two different total RNA
samples and find a high concordance between single-reaction
multiplex PCR/AFM data and data obtained from a panel of 20
independent singleplex qPCR assays. Aside from transcriptional
profiling, this technique could be used to quantify multiple
nucleic acids targets in other assays where molecular
concentration is relevant, such as in studies of genomic copy
number variation, mRNA isoform detection, and analysis of
chromosomal translocations.
■ RESULTS AND DISCUSSION
Multiplex PCR. Ten human genes (see Table S1,
Supporting Information) were chosen as a model biomarker
panel; we measured the difference in expression of transcripts
in this panel between two commercially available total RNA
samples: Universal Total Human Reference RNA (Stratagene)
and FirstChoice Human Brain Reference RNA (Life Tech-
nologies). To verify that all ten genes could be coamplified in
the same reaction, 30 cycles of multiplex RT-PCR were
conducted at primer concentrations listed in Table S1,
Supporting Information, using both total RNA samples, and
separated in 1% agarose gel (Figure S1, Supporting
Information). The Agilent Bioanalyzer DNA high-sensitivity
kit was used to quantify the multiplex PCR after 15
amplification cycles (Figure 1).
AFM Imaging. We used APS-treated mica surfaces to bind
DNA molecules for AFM imaging.17 Note that we did not
purify mRNA from total RNA and used oligo(dT) reverse
transcription primers for simplicity, so the solution after PCR
contains, in addition to amplicons, genomic DNA contami-
nation, rRNA, all mRNAs, and cDNAs. However, as it can be
seen on the AFM image depicted in Figure 2, the most
abundant species on mica surface are amplicon molecules,
distinguishable from the other reaction constituents by length,
height, and persistence length.
Using PCR/AFM, we were able to reliably detect amplicons
after 15 cycles (Figure 3), which is lower than qPCR Ct values
at comparable amounts of initial cDNA (see qPCR data in
Table S2, Supporting Information). In fact, there is a balance in
choosing the number of PCR cycles: too few may result in
decreased specificity and insufficient amount of amplicons,
while too many will distort the initial distribution of nucleic
acid targets; so, the number of cycles should be optimized for
each assay. Here, we used unmodified primers and amplicons.
Labeling of primers at their 5′-end with AFM-detectable labels,
such as streptavaidin or other proteins, or nanoparticles, can
increase the level of multiplexing at least by a factor of 2-fold
(20 targets). Previously, we have shown that sequence-specific
labeling can be used to identify individual transcripts in a
complex mixture containing several thousand distinct species.15
Sequence-specific labeling of amplicons could not only increase
the level of multiplexing but also allow for detection of genetic
variations within the amplicons in cases where the amplicon
length is detectably altered. In order to minimize the number of
steps of our protocol, we used total RNA without enzymatic
digestion of remaining genomic DNA and purification of
mRNA. Although silica column-based purification allows for
specific purification of dsDNA amplicons and elimination of
almost all of the ssRNA and ssDNA, the elution volume for a
typical column is 6−10 μL. However, 0.1 μL or even less is
required for deposition on the mica surface. Using advanced
DNA purification techniques, such as purification by electric
field,18−21 we can potentially increase the sensitivity of this
assay by 100×.
To determine the repeatability of the PCR + AFM
measurement, we separately repeated the 10-plex measure-
ments of Human Reference total RNA, de novo, in triplicate
(see Table S6, Supporting Information). The median
coefficient of variation (standard error/mean) for the
abundances of the ten targets was 0.25 (range of 0.17−0.81).
This compares to a median estimated lower limit of error due
to statistical counting noise of 0.18 (range of 0.05−0.38). The
counting error is a function of the sampling depth (number of
molecules counted per sample), and this type of error can be
arbitrarily reduced by collecting more molecule counts at the
expense of throughput. Note that qPCR itself has been shown
to have a relative error (CV) in the range of 0.10−0.25 across
most of its dynamic range (Ct values of 18−30; the majority of
our qPCR measurements had Ct values in this range). This data
indicates that a 2-fold change in gene expression would be
Figure 3. Relative expression of target mRNAs in brain vs human
reference total RNA. The relative abundance of each target is
determined by AFM (y-axis) vs qPCR (x-axis). Error bars represent
the estimated standard error of measurement for qPCR and PCR +
AFM. The robust linear least-squares fit is indicated by the solid black
line, y = −0.14 + 0.60x, and the dotted black lines represent ±0.5 log2
from the fit. The linear model fits the data well (R2 of the fit is 0.87),
indicating that the AFM data is a good predictor of the qPCR
measurements. Dispersion of the data about the fit vs qPCR, given by
the root mean squared error (RMSE), is 0.87 log2 units. Note that
MMP2 is the only gene where the difference in Ct value for Human
Reference and Brain sample is more than 10 log2 units at 60 °C (see
Table S2, Supporting Information). This fact can be an indicator for
the limits of dynamic range for AFM-based PCR using 1000−2000
molecules; increasing the number of analyzed molecules will improve
the dynamic range at the expense of throughput.
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detected in a single experiment in most cases where the total
number of molecule counts per species is similar to that
reported here. (See Supporting Information for further
discussion of repeatability.)
This is an initial study of applicability of PCR/AFM to
analyze “real” biological material derived from human cells. We
restricted ourselves to gene expression profiling of ten genes.
Undoubtedly, this technique can be applied to virtually any
genetic variation or a combination of genetic variation assayed
in the same tube. While the slow imaging rate of our general
purpose AFM was a practical constraint (∼25 h imaging time
for 2 samples), if a commercially available high scan rate AFM
had been used (e.g., Bruker FastScan or Asylum Cypher), the
assay time would have been considerably reduced, to 1.4 h or
less, which is of similar duration as regular 30−35 cycle qPCR,
and significantly more rapid than existing hybridization-based
detection schemes (14−16 h).1,3 We note that automated
sample handling and image analysis can be easily implemented
using standard methods, as we and others have shown
previously,16,22 and that AFM technology has progressed to
the point that image capture rates can approach that of optical
microscopy.23−27 General purpose AFM instruments are
commonly available in universities and other research
institutions. High scan speed (imaging rate approaching 1
frame per second) AFMs have been commercially available for
several years, are beginning to replace “standard” AFMs in the
installed base, and are often available in shared core facilities as
are quantitative PCR machines and DNA sequencing instru-
ments; the approximate retail price of a state of the art general
purpose high speed AFM is on the order of the former and
much less than the latter. However, the AFM + PCR method
does not require many of the features present in a general
purpose AFM, such as complex z-axis feedback control and
electronics supporting multiple imaging modes (surface
elasticity mapping, electric and magnetic imaging, etc.); a
suitable system can be assembled from commercially available
components for approximately $30,000.
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